EVGN Earnings Date & History
Evogene Ltd (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 4:06 PM ET
Evogene Ltd
Biotechnology
- Next earnings date
- Wednesday, November 18, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-0.28
- Revenue estimate
- $408,000
EVGN earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Tuesday, August 18, 2026 | Q2 2026 | $-0.28 | $-0.13 | +52.8% | $350,000 |
| Wednesday, May 20, 2026 | Q1 2026 | $-0.28 | $-0.60 | -117.9% | $334,000 |
| Thursday, March 5, 2026 | Q4 2025 | $-0.27 | $-0.61 | -130.0% | $314,000 |
| Thursday, November 20, 2025 | Q3 2025 | $-0.42 | $0.44 | +205.2% | $312,000 |
| Tuesday, August 19, 2025 | Q2 2025 | $-0.64 | $-0.62 | +3.5% | $884,000 |
What the market is watching in EVGN's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next EVGN earnings date?
- Evogene Ltd is scheduled to report on Wednesday, November 18, 2026 (Time TBD). Dates can change until the company confirms them.
- Does EVGN report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for EVGN?
- Consensus EPS for the upcoming quarter is $-0.28, on revenue of $408,000.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
EVGN earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.